(Q43248727)

17 November 2017

Evaluating new screening tests for breast cancer (English)

1 reference

17 November 2017

4

1 reference

17 November 2017

2

Nehmat Houssami

1 reference

17 November 2017

3

Bruce Armstrong

1 reference

17 November 2017

Les Irwig

1

1 reference

PMC publication ID

1410890

17 November 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

17 November 2017

1 reference

17 November 2017

332

1 reference

17 November 2017

7543

1 reference

17 November 2017

678-679

1 reference

Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study

17 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410890

Diagnostic performance of digital versus film mammography for breast-cancer screening

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410890

New technologies in screening for breast cancer: a systematic review of their accuracy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410890

Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410890

Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410890

Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410890

Incidence of and treatment for ductal carcinoma in situ of the breast.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410890

Screening for breast cancer

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410890

Breast MRI for Women With Hereditary Cancer Risk

3 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1410890

Breast cancer screening with MRI--what are the data for patients at high risk?

1 December 2018

1 reference

12 December 2020

What should the burden of proof be for acceptance of a new breast-cancer screening technique?

1 reference

12 December 2020

Extra incidence caused by mammographic screening

1 reference

12 December 2020

Comparing dichotomous screening tests when individuals negative on both tests are not verified

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.332.7543.678

1 reference

17 November 2017

1 reference

PMC publication ID

1410890

17 November 2017

PubMed publication ID

16565097

1 reference

PMC publication ID

1410890